STOK peer analysis
Stoke Therapeutics (STOK) against its competitors: price, today's move, 1-year return and market value side by side.
STOK and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BEAM Beam Therapeutics | $27.00 | 4.37% | 14.43% | $2.73B |
| DSGN Design Therapeutics | $10.21 | 5.58% | 55.88% | – |
| IONS Ionis Pharmaceuticals | $39.20 | 1.03% | -47.21% | $6.55B |
| PASG Passage Bio | $3.46 | -1.42% | -48.36% | $11.13M |
| PRQR ProQR Therapeutics | $1.35 | 1.88% | -43.07% | $142.77M |
| SLN Silence Therapeutics | $19.78 | 0.33% | 216.11% | – |
| WVE Wave Life Sciences | $3.34 | 3.73% | -58.15% | $663.68M |
| STOK Stoke Therapeutics | $27.20 | 4.33% | 16.13% | $1.71B |
- STOK's peers: BEAM (Beam Therapeutics), DSGN (Design Therapeutics), IONS (Ionis Pharmaceuticals), PASG (Passage Bio), PRQR (ProQR Therapeutics), SLN (Silence Therapeutics), WVE (Wave Life Sciences).
Updated 2026-11-07 11:54 UTC